T-ACE Oil by TAE/TACE in Patients With Hepatocellular Carcinoma
Status:
Not yet recruiting
Trial end date:
2024-06-30
Target enrollment:
Participant gender:
Summary
The phase I/II, double-blind, randomized study will investigate the efficacy and safety of
TACE/TAE treatment with T-ACE Oil in patients with unresectable hepatocellular carcinoma.